Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.375NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.432NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.241NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.298NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.433NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.214NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.304NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.214.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.577NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.639NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.2.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.270NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.227NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
U.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.50 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.266NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.253NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.305NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.241NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.326NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.255NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.303NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.173NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.362.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.520NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.521NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.383NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.117NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.157NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.187NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.213NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.341NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.89NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.379NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.240NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used